期刊文献+

催乳素延缓hCG诱发大鼠排卵和下调纤溶酶原激活系统在卵巢中的表达 被引量:1

Prolactin Delaying hCG - induced Ovulation and Down Regulating Plasminogen Activator System in Rat Ovary
下载PDF
导出
摘要 给幼龄大鼠注射10IU PMSG,48h后注射7IU hCG,或者hCG加不同剂量的催乳素(PRL).在不同时间取出卵巢,检查输卵管中卵子数和卵巢不同细胞中组织型纤溶酶原激活因子(tPA)和抑制因子(PAI-1)mRNA含量和活性.结果表明:PRL减少hCG诱发的排卵数并有明显剂量和时间抑制曲线.当hCG注射24h后,在两组动物输卵管的卵子数无明显差异.PRL同时抑制hCG所诱发的颗粒细胞tPA表达;与少匕相反PRL还能显著刺激膜一间质细胞PAI-1mRNA表达.上述实验结果表明,PRL只暂时延缓而不是完全抑制hCG诱发的大鼠排卵.上述作用可能是通过抑制纤溶酶激活系统在卵巢中的表达引起的. Immature female rats were injected subcutaneously (sc) with 10 IU pregnant mare serum go-nadotropin (PMSG) to stimulate follicle growth, and 48 h later were followed by injection with 7 IU hCG or 7 IU hCG plus various doses of prolactin (PRL) 15 minutes before hCG injection. The ovaries were examined for the presence of ova , the level of tissue type plasminogen activator (tPA) and plasminogen activator inhibitor type - 1 (PAI - 1) mRNA and activities. PRL dose -dependently decreases ovulation number. The suppression of hCG - induced ovulation by PRL was time -dependent. After the hormone treatment for 24 h, the number of ova in the oviducts in hCG plus PRL - treated groups was not significantly different. PRL was also found to suppress hCG -induced tPA gene expression in granulose cells in a time -dependent manner. In contrast, the PAI - 1 mRNA in the theca -interstitial cells (TI) in the PRL treated groups was higher than that in the corresponding hCG - treated groups. The data provided here suggest that PRL tem-porsrily delays, but does not completely inhibit hCG -induced ovulation, which may be caused by a temporal suppression of PA - mediated proteolysis.
出处 《生殖与避孕》 CAS CSCD 北大核心 1998年第1期12-16,共5页 Reproduction and Contraception
基金 中国科学院重点项目 国家自然科学基金 瑞典医学委员会支持研究项目
关键词 催乳素 HCG 纤溶酶原 激活因子 表达 排卵 Prolactin, Tissue type plasminogen activator, Plasminogen activatorinhibitor type -1, Ovulation
  • 相关文献

参考文献7

  • 1刘以训,Sci China B,1994年,37卷,271页
  • 2彭晓蓉,Eur J Biochem,1993年,214卷,147页
  • 3刘以训,Sci China B,1993年,36卷,319页
  • 4Hu Zhaoyuan,生理学报,1993年,45卷,510页
  • 5刘以训,Eur J Biochem,1991年,195卷,549页
  • 6刘以训,Sci Sin,1988年,31卷,47页
  • 7刘以训,Mol Cell Endocrinol,1987年,54卷,221页

同被引文献10

  • 1张娜,刘复权,李彦群,马洪骏.转化生长因子-α及其受体在多囊卵巢综合征大鼠中的表达[J].河北医科大学学报,2005,26(1):5-7. 被引量:10
  • 2赵君利,陈子江,赵跃然,赵力新,王来成,唐蓉,马增香.纤溶酶原激活物抑制因子1基因启动子区4G和5G多态基因型分布及其与多囊卵巢综合征的相关性研究[J].中华妇产科杂志,2005,40(8):528-531. 被引量:17
  • 3丁晓芳,田永红,李红钢,熊锦文,熊承良.尿激酶型纤溶酶原激活因子在小鼠精-卵接触前通讯和体外受精中作用初探[J].生殖与避孕,2006,26(1):3-9. 被引量:3
  • 4Beloosesky R,Gold R,Almog B,et al.Induction of polycystic ovary by testosterone in immature female rats:Modulation of apoptosis and attenuation of glucose/insulin ratio.Int J Mol Med.2004,14(2):207-15.
  • 5Lara HE,Dissen GA,Leyton V,et al.An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat.Endocrinology,2000,141(3):1 059-72.
  • 6Liu Yi-xun,Peng Xiao-rong & Ny Tor.Tissue-speicific and time-coordinated hormone regulation of plasminogen activator inhibitor type-1 and tissue-type plasminogen activator in the rat ovary during gonadotropin-induced ovulation.Eur J Biochem,1991,195(2):549-55.
  • 7Glueck CJ,Sieve L,Zhu B,et al.Plasminogen activator inhibitor activity,4G5G polymorphism of the plasminogen activator inhibitor 1 gene,and first-trimester miscarriage in women with polycystic ovary syndrome.Metabolism,2006,55(3):345-52.
  • 8Diamanti-Kandarakis E,Palionko G,Alexandraki K,et al.The prevalence of4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovary syndrome and its association with plasma PAI-1 level.Eur J Endocrinol,2004,150(6):793-8.
  • 9Sills ES,Drews CD,Perloe M,et al.Absence of profound hyperinsulinism in polycystic ovary syndrome is associated with subtle elevations in plasminogen activator inhibitor system.Gynecol Endocrinol,2003,17(3):231-7.
  • 10朱辉,倪江,姚兰春,边淑玲,姜杰,黄淇.大鼠多囊卵巢动物模型的实验研究[J].哈尔滨医科大学学报,1999,33(3):187-188. 被引量:34

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部